In vivo reprogramming of human telomerase reverse transcriptase (hTERT) by trans-splicing ribozyme to target tumor cells.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Methods in molecular biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-60761-657-3_20PMID 20387158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo

  2009cited by this paper
• In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells.

  2008cited by this paper
• Antitumor Effects of Systemically Delivered Adenovirus Harboring Trans-Splicing Ribozyme in Intrahepatic Colon Cancer Mouse Model

  2008cited by this paper
• Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript.

  2005cited by this paper
• Ribozymes in the age of molecular therapeutics.

  2004cited by this paper
• Ribozyme-mediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA.

  2004cited by this paper
• Ribozymes: recent advances in the development of RNA tools.

  2003cited by this paper
• Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing.

  2003cited by this paper
• HIV-1 TAR as Anchoring Site for Optimized Catalytic RNAs

  2003cited by this paper
• Functional repair of a mutant chloride channel using a trans-splicing ribozyme.

  2002cited by this paper
• Ribozyme gene therapy: applications for molecular medicine.

  2001cited by this paper
• Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors.

  2000cited by this paper
• Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA.

  2000cited by this paper
• Ribozyme-mediated trans-splicing of a trinucleotide repeat

  1998cited by this paper
• Ribozyme-Mediated Repair of Sickle β-Globin mRNAs in Erythrocyte Precursors

  1998cited by this paper
• Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors.

  1998cited by this paper
• Tagging ribozyme reaction sites to follow trans–splicing in mammalian cells

  1996cited by this paper
• Ribozyme-mediated repair of defective mRNA by targeted trans-splicing

  1994cited by this paper
• Experimental nude mouse model of human colorectal cancer liver metastases.

  1986cited by this paper
• One binding site determines sequence specificity of Tetrahymena pre-rRNA self-splicing, trans-splicing, and RNA enzyme activity.

  1986cited by this paper

• Small Animal PET Imaging of hTERT RNA-Targeted HSV1-tk Gene Expression with Trans-Splicing Ribozyme

  2019cites this paper
• Image-aided Suicide Gene Therapy Utilizing Multifunctional hTERT-targeting Adenovirus for Clinical Translation in Hepatocellular Carcinoma

  2016cites this paper
• Low-dose cisplatin converts the tumor microenvironment into a permissive state for HSVtk-induced antitumor immunity in HPV16-related tonsillar carcinoma.

  2015cites this paper
• Computational prediction of efficient splice sites for trans-splicing ribozymes.

  2012cites this paper
• Selective and efficient retardation of cancers expressing cytoskeleton‐associated protein 2 by targeted RNA replacement

  2011cites this paper